Finance

Lists
SYRS:OTCMKTS
Syros Pharmaceuticals Inc
0,00040 $
0,00%
(0,00) 1D
15 հոկ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRS...
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
12,88 հզր
Avg. vol.
16,12 հզր
Volume
1,23 հզր
52-wk high
0,02 $
52-wk low
0,00 $
Beta
1,66
Shares outstanding
26,83 մլն
No. of employees
68
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
12,88 հզր
Avg. vol.
16,12 հզր
Volume
1,23 հզր
52-wk high
0,02 $
52-wk low
0,00 $
Beta
1,66
Shares outstanding
26,83 մլն
No. of employees
68
News stories
From web sources and news partners
About Syros Pharmaceuticals Inc
CEO-
Employees68
Founded2011
Headquarters-
Sector-
Websitesyros.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2023 թ. դեկ
2024 թ. մրտ
2024 թ. հնս
2024 թ. սեպ
Revenue
386,00 հզր
-
-
-
Cost of goods sold
-
-
-
20,53 մլն
Cost of revenue
-
-
-
20,53 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
5,66 մլն
Operating expense
-
-
-
5,66 մլն
Total operating expenses
-
-
-
26,18 մլն
Operating income
-
-
-
-26,18 մլն
Other non operating income
-
-
-
20,30 մլն
EBT including unusual items
-
-
-
-6,40 մլն
EBT excluding unusual items
-
-
-
-6,40 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-6,40 մլն
Net profit margin
-
-
-
-
Earnings per share
-2,22
-0,10
-0,59
-0,16
Interest and investment income
-
-
-
793,00 հզր
Interest expense
-
-
-
-1,31 մլն
Net interest expenses
-
-
-
-519,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-25,86 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps